Frequently Asked Questions (FAQs) for RFA-NS-12-010 - Exploratory Laboratory and Analysis Projects in Parkinson’s Disease Biomarkers (U18) and RFA-NS-12-011 - Studies in Parkinson's Disease Biomarkers Discovery (U01)
Release Date: April 19, 2012
National Institute of Neurological Disorders and Stroke (NINDS)
On March 16th, 2012, the NINDS issued two Funding Opportunity Announcements (FOAs): RFA-NS-12-010 - Exploratory Laboratory and Analysis Projects in Parkinson's Disease Biomarkers (U18) and RFA-NS-12-011 - Studies in Parkinson's Disease Biomarkers Discovery (U01). The goal of RFA-NS-12-010 is to stimulate innovation and development of technologies and reagents that will accelerate the discovery of biological biomarkers for Parkinson’s disease (PD). The goal of RFA-NS-12-011 is to support hypothesis driven clinical research to discover biomarkers that will improve the efficiency and outcome of Phase II clinical trials for Parkinson’s Disease (PD) and to support the collection of clinical data and new biological specimens that will be used for biomarker exploratory efforts under the NINDS Parkinson’s Disease Biomarkers Program (PDBP).
To date, several questions about these FOAs have been submitted from various investigators. The purpose of this Notice is to inform potential applicants that a list of Frequently Asked Questions (FAQs) and answers is available at (http://www.ninds.nih.gov/pdbp/). These FAQs may be updated periodically without additional notice.
For questions or further information, contact:
Katrina Gwinn MD
National Institute of Neurological Disorders and Stroke
6001 Executive Blvd Room 2143
Bethesda MD 20892
Weekly TOC for this Announcement
NIH Funding Opportunities and Notices
Office of Extramural
National Institutes of Health (NIH)
9000 Rockville Pike
Bethesda, Maryland 20892
Department of Health
and Human Services (HHS)
NIH . . . Turning Discovery Into Health
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.